Arca Biopharma sell StockNews.com
Start price
28.04.24
/
50%
€3.30
Target price
28.04.25
-
Performance (%)
-15.15%
Price
26.07.24
€2.88
Summary
This prediction is currently active. The prediction for Arca Biopharma shows a convincing performance of -15.15%. This prediction currently runs until 28.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | -8.861% | -8.861% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat